IL74671A0 - Improvements in or relating to crystalline ceftazidime salts - Google Patents

Improvements in or relating to crystalline ceftazidime salts

Info

Publication number
IL74671A0
IL74671A0 IL74671A IL7467185A IL74671A0 IL 74671 A0 IL74671 A0 IL 74671A0 IL 74671 A IL74671 A IL 74671A IL 7467185 A IL7467185 A IL 7467185A IL 74671 A0 IL74671 A0 IL 74671A0
Authority
IL
Israel
Prior art keywords
relating
salts
crystalline ceftazidime
ceftazidime
crystalline
Prior art date
Application number
IL74671A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL74671A0 publication Critical patent/IL74671A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL74671A 1984-03-26 1985-03-20 Improvements in or relating to crystalline ceftazidime salts IL74671A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/593,441 US4537959A (en) 1984-03-26 1984-03-26 Crystalline cephalosporin antibiotic salt

Publications (1)

Publication Number Publication Date
IL74671A0 true IL74671A0 (en) 1985-06-30

Family

ID=24374724

Family Applications (1)

Application Number Title Priority Date Filing Date
IL74671A IL74671A0 (en) 1984-03-26 1985-03-20 Improvements in or relating to crystalline ceftazidime salts

Country Status (16)

Country Link
US (1) US4537959A (ko)
EP (1) EP0157538A3 (ko)
JP (1) JPS60215689A (ko)
KR (1) KR870000829B1 (ko)
AU (1) AU575137B2 (ko)
CA (1) CA1228851A (ko)
DK (1) DK131785A (ko)
ES (1) ES8606358A1 (ko)
GR (1) GR850708B (ko)
HU (1) HU194253B (ko)
IL (1) IL74671A0 (ko)
NZ (1) NZ211509A (ko)
PH (1) PH21943A (ko)
PT (1) PT80133B (ko)
SU (1) SU1356963A3 (ko)
ZA (1) ZA852042B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
GB8406218D0 (en) * 1984-03-09 1984-04-11 Glaxo Group Ltd Process
US4616080A (en) * 1984-07-02 1986-10-07 Eli Lilly And Company Simplified process of forming crystalline ceftazidime pentahydrate
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
AT387390B (de) * 1986-10-07 1989-01-10 Biochemie Gmbh Verfahren zur herstellung des antibiotikums (6r,7r)-7-(2-(2-amino-4-thiazolyl)-2-(2-carboxy
US4954624A (en) * 1986-10-07 1990-09-04 Sandoz Ltd. Process for the production of cephalosporin derivatives
US5021564A (en) * 1987-02-02 1991-06-04 Eli Lilly And Company Process for preparing ceftazidime pentahydrate
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3788279T2 (de) * 1987-06-25 1994-06-16 Banyu Pharma Co Ltd Kristalline cephalosporinzusammensetzungen, verfahren und zwischenprodukte für ihre herstellung.
GB8802622D0 (en) * 1988-02-05 1988-03-02 Glaxo Group Ltd Chemical compound
DE10158488A1 (de) † 2001-11-28 2003-06-12 Wolff Cellulosics Gmbh & Co Kg Lösungsverzögerte Celluloseether und ein Verfahren zu ihrer Herstellung
CN102924483B (zh) * 2012-10-31 2015-06-17 海南合瑞制药股份有限公司 一种头孢他啶晶体化合物、其制备方法及其无菌混合粉形式的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
SE449996B (sv) * 1979-10-02 1987-06-01 Glaxo Group Ltd (6r,7r)-7-/(z)-2-(2-aminotiazol-4-yl)-2-(2-karboxiprop-2-oxiimino)acetamidol/-3-(1-pyridiniummetyl)cef-3-em-4-karboxylat i form av en kristallin bishydroklorid farmaceutisk komposition derav samt anvendning som mellanpr
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim

Also Published As

Publication number Publication date
DK131785D0 (da) 1985-03-22
HU194253B (en) 1988-01-28
ES541505A0 (es) 1986-04-16
KR870000829B1 (ko) 1987-04-23
EP0157538A3 (en) 1986-10-08
GR850708B (ko) 1985-07-19
AU575137B2 (en) 1988-07-21
AU4025085A (en) 1985-10-03
PH21943A (en) 1988-04-15
EP0157538A2 (en) 1985-10-09
PT80133B (en) 1987-03-23
US4537959A (en) 1985-08-27
JPS60215689A (ja) 1985-10-29
NZ211509A (en) 1987-11-27
PT80133A (en) 1985-04-01
ES8606358A1 (es) 1986-04-16
ZA852042B (en) 1986-10-29
KR850006425A (ko) 1985-10-05
DK131785A (da) 1985-09-27
SU1356963A3 (ru) 1987-11-30
HUT36798A (en) 1985-10-28
CA1228851A (en) 1987-11-03

Similar Documents

Publication Publication Date Title
GB8401005D0 (en) Formate salts
PH21943A (en) Improvements in or relating to crystalline ceftazidime salts
DE3569533D1 (en) Phosphonic-acid salts
GB2161843B (en) Improvements in or relating to walls
GB2155654B (en) Improvements in or relating to eyeguards
IL75615A0 (en) Improvements in or relating to a crystallization process for ceftazidime
EP0156550A3 (en) Improvements in or relating to pipework
CY1505A (en) Improvements in or relating to cephalosporin derivatives
DE3562489D1 (en) Improvements in or relating to fructose crystallization
ZA857613B (en) Crystalline cephalosporin hydrohalide salts
GB2171082B (en) Improvements in or relating to facsimile recorders
GB2164034B (en) Preparing oxydicarboxylic acid salts
IL75593A0 (en) Improvements in or relating to ceftazidime
DE3479659D1 (en) Improvements in or relating to a crystalline 7-(r)-amino-3-(1-pyridiniummethyl)-ceph-3-em-4-carboxylate
GB2145899B (en) Improvements in or relating to telecines
ZA859129B (en) Crystalline galloborosilicates
GB2157284B (en) 6-b-halopenicillanic acid salts
GB2166424B (en) Improvements in or relating to materials
GB2167022B (en) Improvements in or relating to bogies
IE842313L (en) Crystalline benzothiazine salts
GB8414046D0 (en) Crystalline salts
IL85438A0 (en) Improvements in or relating to dobutamine salts
PT81238B (en) Improvements in or relating to puschairs
ZA856444B (en) Cyclimmonium salts
IE841576L (en) Methyllevallorphanium salts